Gaganjit Kaur: Nesfatin-1 as a Neuroprotective Target in Hyperhomocysteinemia-Induced VCID
Gaganjit Kaur, Associate Professor at Maharaja Agrasen University, shared a post on LinkedIn, about a recent article by Gaganjit Kaur et al., published in International Journal of Drug Delivery Technology adding:
“L-Methionine 1.7 g/kg; for 8 weeks, orally, induced hyperhomocysteinemia, and consequent VCID.
Nesfatin-1 is a neuropeptide, highly expressed in brain.
Nesfatin-1 is involved in appetite regulation, mitochondrial biogenesis and energy production, neuroprotection.
In addition Nesfatin-1 exhibits potent anti-neuroinflammatory, antioxidant and antiapoptotic effect․”
Tiltle: Nesfatin-1 Ameliorated Cognitive Functions In L-Methionine-Induced Vascular Cognitive Impairment and Dementia By Restoring Brain Mitochondrial Activity
Authors: Gaganjit Kaur, Sushma Devi, Manish Shukla, Manish Kumar, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, Maharaja Agrasen School of Pharmacy, Maharaja Agrasen University, Baddi, Solan, Himachal Pradesh, India
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering